Microarray analysis of UVB-regulated genes in keratinocytes: Downregulation of angiogenesis inhibitor thrombospondin-1

Journal of Dermatological Science

Volumn 34, Issue 3, 2004, Pages 185-194

  Howell, B G ^a   Wang, B ^a   Freed, I ^a   Mamelak, A J ^a   Watanabe, H ^a   Sauder, D N ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Gene expression profiling; Microarray; Platelet derived endothelial cell growth factor; Skin cancer; Thrombospondin 1; Ultraviolet B irradiation

Indexed keywords

ANGIOGENESIS INHIBITOR; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THROMBOSPONDIN 1;

ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; KERATINOCYTE; NEWBORN; PRIORITY JOURNAL; RADIATION DOSE; REGULATORY MECHANISM; ULTRAVIOLET B RADIATION; UPREGULATION;

CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION; HUMANS; KERATINOCYTES; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SKIN NEOPLASMS; THROMBOSPONDIN 1; ULTRAVIOLET RAYS;

EID: 2142765862     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2004.01.004     Document Type: Article

References (83)

1. Kricker A., Armstrong B.K., Parkin D.M. Measurement of skin cancer incidence. Health Rep. 5:1993;63-66
2. Kripke M.L. Effects of UV radiation on tumor immunity. J. Natl. Cancer Inst. 82:1990;1392-1396
3. Kripke M.L. Immunological unresponsiveness induced by ultraviolet radiation. Immunol. Rev. 80:1984;87-102
4. Grabbe S., Bruvers S., Lindgren A.M., Hosoi J., Tan K.C., Granstein R.D. Tumor antigen presentation by epidermal antigen-presenting cells in the mouse: modulation by granulocyte-macrophage colony-stimulating factor, tumor necrosis factor alpha, and ultraviolet radiation. J. Leukoc. Biol. 52:1992;209-217
5. Grabbe S., Bruvers S., Granstein R.D. Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen-presenting cells. J. Invest. Dermatol. 102:1994;67-73
6. Grabbe S., Bruvers S., Beissert S., Granstein R.D. Interferon-gamma inhibits tumor antigen presentation by epidermal antigen-presenting cells. J. Leukoc. Biol. 55:1994;695-701
7. Beissert S., Hosoi J., Grabbe S., Asahina A., Granstein R.D. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J. Immunol. 154:1995;1280-1286
8. Ullrich S.E. Modulation of immunity by ultraviolet radiation: key effects on antigen presentation. J. Invest. Dermatol. 105:1995;30S-36S
9. Wang B., Zhuang L., Fujisawa H., Shinder G.A., Feliciani C., Shivji G.M., et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J. Immunol. 162:1999;277-283
10. Takashima A. UVB-dependent modulation of epidermal cytokine network: roles in UVB-induced depletion of Langerhans cells and dendritic epidermal T cells. J. Dermatol. 22:1995;876-887
11. Wang B., Amerio P., Sauder D.N. Role of cytokines in epidermal Langerhans cell migration. J. Leukoc. Biol. 66:1999;33-39
12. Weiss J.M., Renkl A.C., Denfeld R.W., de Roche R., Spitzlei M., Schopf E., et al. Low-dose UVB radiation perturbs the functional expression of B7.1 and B7.2 co-stimulatory molecules on human Langerhans cells. Eur. J. Immunol. 25:1995;2858-2862
13. Rattis F.M., Concha M., Dalbiez-Gauthier C., Courtellemont P., Schmitt D., Peguet-Navarro J. Effects of ultraviolet B radiation on human Langerhans cells: functional alteration of CD86 upregulation and induction of apoptotic cell death. J. Invest. Dermatol. 111:1998;373-379
14. Stingl G., Gazze-Stingl L.A., Aberer W., Wolff K. Antigen presentation by murine epidermal Langerhans cells and its alteration by ultraviolet B light. J. Immunol. 127:1981;1707-1713
15. Sauder D.N. Interleukin 1. Arch. Dermatol. 125:1989;679-682
16. Kondo S., Kooshesh F., Sauder D.N. Penetration of keratinocyte-derived cytokines into basement membrane. J. Cell Physiol. 171:1997;190-195
17. Kondo S., Sauder D.N. Keratinocyte-derived cytokines and UVB-induced immunosuppression. J. Dermatol. 22:1995;888-893
18. Lee H.S., Kooshesh F., Sauder D.N., Kondo S. Modulation of TGF-beta 1 production from human keratinocytes by UVB. Exp. Dermatol. 6:1997;105-110
19. Fujisawa H., Kondo S., Wang B., Shivji G.M., Sauder D.N. The expression and modulation of IFN-alpha and IFN-beta in human keratinocytes. J. Interferon Cytokine Res. 17:1997;721-725
20. Paglia D., Kondo S., Ng K.M., Sauder D.N., McKenzie R.C. Leukaemia inhibitory factor is expressed by normal human keratinocytes in vitro and in vivo. Br. J. Dermatol. 134:1996;817-823
21. Tron V.A., Coughlin M.D., Jang D.E., Stanisz J., Sauder D.N. Expression and modulation of nerve growth factor in murine keratinocytes (PAM 212). J. Clin. Invest. 85:1990;1085-1089
22. Nozaki S., Abrams J.S., Pearce M.K., Sauder D.N. Augmentation of granulocyte/macrophage colony-stimulating factor expression by ultraviolet irradiation is mediated by interleukin 1 in Pam 212 keratinocytes. J. Invest. Dermatol. 97:1991;10-14
23. Venner T.J., Sauder D.N., Feliciani C., McKenzie R.C. Interleukin-8 and melanoma growth-stimulating activity (GRO) are induced by ultraviolet B radiation in human keratinocyte cell lines. Exp. Dermatol. 4:1995;138-145
24. Kondo S., Kono T., Sauder D.N., McKenzie R.C. IL-8 gene expression and production in human keratinocytes and their modulation by UVB. J. Invest. Dermatol. 101:1993;690-694
25. Gallo R.L., Staszewski R., Sauder D.N., Knisely T.L., Granstein R.D. Regulation of GM-CSF and IL-3 production from the murine keratinocyte cell line PAM 212 following exposure to ultraviolet radiation. J. Invest. Dermatol. 97:1991;203-209
26. McKenzie R.C. Ultraviolet radiation B (UVB)-induction of Leukaemia Inhibitory Factor (LIF) in human keratinocytes. Photodermatol. Photoimmunol. Photomed. 17:2001;284-285
27. Chaturvedi V., Qin J.Z., Denning M.F., Choubey D., Diaz M.O., Nickoloff B.J. Abnormal NF-κB signaling pathway with enhanced susceptibility to apoptosis in immortalized keratinocytes. J. Dermatol. Sci. 26:2001;67-78
28. Qin J.Z., Chaturvedi V., Denning M.F., Choubey D., Diaz M.O., Nickoloff B.J. Role of NF-κB in the apoptotic-resistant phenotype of keratinocytes. J. Biol. Chem. 274:1999;37957-37964
29. Chen W., Borchers A.H., Dong Z., Powell M.B., Bowden G.T. UVB irradiation-induced activator protein-1 activation correlates with increased c-fos gene expression in a human keratinocyte cell line. J. Biol. Chem. 273:1998;32176-32181
30. Ariizumi K., Bergstresser P.R., Takashima A. Wavelength-specific induction of immediate early genes by ultraviolet radiation. J. Dermatol. Sci. 12:1996;147-155
31. Merryman J.I., Neilsen N., Stanton D.D. Transforming growth factor-beta enhances the ultraviolet-mediated stress response in p53-/- keratinocytes. Int. J. Oncol. 13:1998;781-789
32. Wan Y.S., Wang Z.Q., Shao Y., Voorhees J.J., Fisher G.J. Ultraviolet irradiation activates PI 3-kinase/AKT survival pathway via EGF receptors in human skin in vivo. Int. J. Oncol. 18:2001;461-466
33. Buckman S.Y., Gresham A., Hale P., Hruza G., Anast J., Masferrer J., et al. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis. 19:1998;723-729
34. Chiarugi V., Magnelli L., Gallo O. Cox-2, iNOS and p53 as play-makers of tumor angiogenesis. Int. J. Mol. Med. 2:1998;715-719
35. Wehrli P., Viard I., Bullani R., Tschopp J., French L.E. Death receptors in cutaneous biology and disease. J. Invest. Dermatol. 115:2000;141-148
36. Li G., Ho V.C., Mitchell D.L., Trotter M.J., Tron V.A. Differentiation-dependent p53 regulation of nucleotide excision repair in keratinocytes. Am. J. Pathol. 150:1997;1457-1464
37. Tron V.A., Li G., Ho V., Trotter M.J. Ultraviolet radiation-induced p53 responses in the epidermis are differentiation-dependent. J. Cutan. Med. Surg. 3:1999;280-283
38. Schena M., Shalon D., Davis R.W., Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 270:1995;467-470
39. Shalon D., Smith S.J., Brown P.O. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res. 6:1996;639-645
40. Schena M., Shalon D., Heller R., Chai A., Brown P.O., Davis R.W. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc. Natl. Acad. Sci. U.S.A. 93:1996;10614-10619
41. Kock A., Schwarz T., Kirnbauer R., Urbanski A., Perry P., Ansel J.C., et al. Human keratinocytes are a source for tumor necrosis factor alpha: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J. Exp. Med. 172:1990;1609-1614
42. Kawara S., Mydlarski R., Mamelak A.J., Freed I., Wang B., Watanabe H., et al. Low-dose ultraviolet B rays alter the mRNA expression of the circadian clock genes in cultured human keratinocytes. J. Invest. Dermatol. 119:2002;1220-1223
43. Bunone G., Vigneri P., Mariani L., Buto S., Collini P., Pilotti S., et al. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am. J. Pathol. 155:1999;1967-1976
44. Yarwood S.J., Woodgett J.R. Extracellular matrix composition determines the transcriptional response to epidermal growth factor receptor activation. PNAS. 98:2001;4472-4477
45. Yarosh D., Both D., Kibitel J., Anderson C., Elmets C., Brash D., et al. Regulation of TNFalpha production and release in human and mouse keratinocytes and mouse skin after UV-B irradiation. Photodermatol. Photoimmunol. Photomed. 16:2000;263-270
46. Leverkus M., Yaar M., Eller M.S., Tang E.H., Gilchrest B.A. Post-transcriptional regulation of UV induced TNF-alpha expression. J. Invest. Dermatol. 110:1998;353-357
47. Schwarz A., Bhardwaj R., Aragane Y., Mahnke K., Riemann H., Metze D., et al. Ultraviolet-B-induced apoptosis of keratinocytes: evidence for partial involvement of tumor necrosis factor-alpha in the formation of sunburn cells. J. Invest. Dermatol. 104:1995;922-927
48. Rivas J.M., Ullrich S.E. The role of IL-4, IL-10, and TNF-alpha in the immune suppression induced by ultraviolet radiation. J. Leukoc. Biol. 56:1994;769-775
49. Zhuang L., Wang B., Shinder G.A., Shivji G.M., Mak T.W., Sauder D.N. TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation. J. Immunol. 162:1999;1440-1447
50. Li D., Turi T.G., Schuck A., Freedberg I.M., Khitrov G., Blumenberg M. Rays and arrays: the transcriptional program in the response of human epidermal keratinocytes to UVB illumination. FASEB J. 15:2001;2533-2535
51. Sesto A., Navarro M., Burslem F., Jorcano J.L. Analysis of the ultraviolet B response in primary human keratinocytes using oligonucleotide microarrays. Proc. Natl. Acad. Sci. U.S.A. 99:2002;2965-2970
52. Murakami T., Fujimoto M., Ohtsuki M., Nakagawa H. Expression profiling of cancer-related genes in human keratinocytes following non-lethal ultraviolet B irradiation. J. Dermatol. Sci. 27:2001;121-129
53. Takao J., Ariizumi K., Dougherty I.I., Cruz P.D. Jr. Genomic scale analysis of the human keratinocyte response to broad-band ultraviolet-B irradiation. Photodermatol. Photoimmunol. Photomed. 18:2002;5-13
54. Marionnet C., Bernerd F., Dumas A., Verrecchia F., Mollier K., Compan D., et al. Modulation of gene expression induced in human epidermis by environmental stress in vivo. J. Invest. Dermatol. 121:2003;1447-1458
55. Becker B., Vogt T., Landthaler M., Stolz W. Detection of differentially regulated genes in keratinocytes by cDNA array hybridization: Hsp27 and other novel players in response to artificial ultraviolet radiation. J. Invest. Dermatol. 116:2001;983-988
56. Wiechen K., Diatchenko L., Agoulnik A., Scharff K.M., Schober H., Arlt K., et al. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am. J. Pathol. 159:2001;1635-1643
57. Razani B., Schlegel A., Liu J., Lisanti M.P. Caveolin-1, a putative tumour suppressor gene. Biochem. Soc. Trans. 29:2001;494-499
58. Wiechen K., Sers C., Agoulnik A., Arlt K., Dietel M., Schlag P.M., et al. Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am. J. Pathol. 158:2001;833-839
59. Liu J., Lee P., Galbiati F., Kitsis R.N., Lisanti M.P. Caveolin-1 expression sensitizes fibroblastic and epithelial cells to apoptotic stimulation. Am. J. Physiol. Cell Physiol. 280:2001;C823-C835
60. Lawler J.W., Slayter H.S., Coligan J.E. Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J. Biol. Chem. 253:1978;8609-8616
61. Boukamp P., Bleuel K., Popp S., Vormwald-Dogan V., Fusenig N.E. Functional evidence for tumor-suppressor activity on chromosome 15 in human skin carcinoma cells and thrombospondin-1 as the potential suppressor. J. Cell Physiol. 173:1997;256-260
62. Streit M., Velasco P., Brown L.F., Skobe M., Richard L., Riccardi L., et al. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am. J. Pathol. 155:1999;441-452
63. Streit M., Riccardi L., Velasco P., Brown L.F., Hawighorst T., Bornstein P., et al. Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc. Natl. Acad. Sci. U.S.A. 96:1999;14888-14893
64. Detmar M. The role of VEGF and thrombospondins in skin angiogenesis. J. Dermatol. Sci. 24(Suppl. 1):2000;S78-S84
65. Yano K., Oura H., Detmar M. Targeted overexpression of the angiogenesis inhibitor thrombospondin-1 in the epidermis of transgenic mice prevents ultraviolet-B-induced angiogenesis and cutaneous photo-damage. J. Invest. Dermatol. 118:2002;800-805
66. Sage E.H. Regulation of interactions between cells and extracellular matrix: a command performance on several stages. J. Clin. Invest. 107:2001;781-783
67. Bornstein P. Diversity of function is inherent in matricellular proteins: an appraisal of thrombospondin 1. J. Cell Biol. 130:1995;503-506
68. Murphy-Ullrich J.E. The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state? J. Clin. Invest. 107:2001;785-790
69. Sage E.H., Bornstein P. Extracellular proteins that modulate cell-matrix interactions. SPARC, tenascin, and thrombospondin. J. Biol. Chem. 266:1991;14831-14834
70. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:1995;27-31
71. Mettouchi A., Cabon F., Montreau N., Vernier P., Mercier G., Blangy D., et al. SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts. EMBO J. 13:1994;5668-5678
72. Kim S.A., Um S.J., Kang J.H., Hong K.J. Expression of thrombospondin-1 in human hepatocarcinoma cell lines and its regulation by transcription factor Jun/AP-1. Mol. Cell Biochem. 216:2001;21-29
73. Slack J.L., Bornstein P. Transformation by v-src causes transient induction followed by repression of mouse thrombospondin-1. Cell Growth Differ. 5:1994;1373-1380
74. Tikhonenko A.T., Black D.J., Linial M.L. Viral Myc oncoproteins in infected fibroblasts down-modulate thrombospondin-1, a possible tumor suppressor gene. J. Biol. Chem. 271:1996;30741-30747
75. Li Q., Ahuja N., Burger P.C., Issa J.P. Methylation and silencing of the Thrombospondin-1 promoter in human cancer. Oncogene. 18:1999;3284-3289
76. Bleuel K., Popp S., Fusenig N.E., Stanbridge E.J., Boukamp P. Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vascularization. Proc. Natl. Acad. Sci. U.S.A. 96:1999;2065-2070
77. Laderoute K.R., Alarcon R.M., Brody M.D., Calaoagan J.M., Chen E.Y., Knapp A.M., et al. Opposing effects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor. Clin. Cancer Res. 6:2000;2941-2950
78. Weinstat-Saslow D.L., Zabrenetzky V.S., VanHoutte K., Frazier W.A., Roberts D.D., Steeg P.S. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential, and angiogenesis. Cancer Res. 54:1994;6504-6511
79. Fontanini G., Boldrini L., Calcinai A., Chine S., Lucchi M., Mussi A., et al. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density. Clin. Cancer Res. 5:1999;155-161
80. Locopo N., Fanelli M., Gasparini G. Clinical significance of angiogenic factors in breast cancer. Breast Cancer Res. Treat. 52:1998;159-173
81. Gasparini G., Toi M., Biganzoli E., Dittadi R., Fanelli M., Morabito A., et al. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis. Oncology. 60:2001;72-80
82. Fukuiwa T., Takebayashi Y., Akiba S., Matsuzaki T., Hanamure Y., Miyadera K., et al. Expression of thymidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics. Cancer. 85:1999;960-969
83. Giatromanolaki A., Fountzilas G., Koukourakis M.I., Arapandoni P., Theologi V., Kakolyris S., et al. Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation. Clin. Exp. Metastasis. 16:1998;665-672